For practices, companies, investors & operators
Scientific & Commercial Due Diligence
Test the story before committing capital, reputation, or resources.
Health and longevity opportunities frequently arrive with two narratives: a scientific narrative about why something should work, and a commercial narrative about why the market should reward it. Either one can fail independently.
Scientific & Commercial Due Diligence investigates both.
What diligence can examine
- Scientific: claimed mechanism, quality of research, human and preclinical evidence, reproducibility
- Scientific: relevant negative studies, safety information, evidence gaps, strength of endpoints
- Scientific: scientific consensus, disagreement, and regulatory context
- Commercial: market structure, competitors, pricing, substitutes, customer segments
- Commercial: growth signals, differentiation, business model, barriers to entry, distribution
- Commercial: category maturity and relevant market risks
The central question
- The goal is not merely to ask whether a claim is technically possible. It is to ask: what would have to be true for this opportunity's scientific and commercial thesis to be correct — and what evidence do we have that those things are true?
Deliverables
- Executive diligence memorandum and scientific evidence dossier.
- Competitive landscape, risk register, and claim-by-claim assessment.
- Source package, market dataset, unanswered-question list, and areas requiring specialist legal, regulatory, financial, or clinical review.
Scope
We provide research and analytical support. The engagement does not constitute legal advice, investment advice, accounting advice, or medical advice.
Test the story before committing capital, reputation, or resources.
Discuss a Diligence Project